Difference between revisions of "Part:BBa K3610056:Design"
(→Design Notes) |
(→References) |
||
Line 14: | Line 14: | ||
===References=== | ===References=== | ||
+ | Inobe, Tomonao; Nukina, Nobuyuki (2016): Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. In: Journal of bioscience and bioengineering 122 (1), S. 40–46. DOI: 10.1016/j.jbiosc.2015.12.004. | ||
+ | Kolos, Jürgen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix (2018): FKBP Ligands—Where We Are and Where to Go? In: Frontiers in Pharmacology 9, S. 1425. DOI: 10.3389/fphar.2018.01425. |
Revision as of 14:37, 9 October 2020
FRB / SmallBit NanoLuc
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
None
Source
BBa_K3610023, BBa_K416001, BBa_K3168003
References
Inobe, Tomonao; Nukina, Nobuyuki (2016): Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. In: Journal of bioscience and bioengineering 122 (1), S. 40–46. DOI: 10.1016/j.jbiosc.2015.12.004. Kolos, Jürgen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix (2018): FKBP Ligands—Where We Are and Where to Go? In: Frontiers in Pharmacology 9, S. 1425. DOI: 10.3389/fphar.2018.01425.